JEREMY TERRO: Open Payments
NPI 1568901338 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,296 in 109 payments from 27 companies in 2025. Trend: 2023 $1,341 · 2024 $1,741 · 2025 $2,296
Food & beverage: $2,126Education: $170
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $485 |
| Axsome Therapeutics, Inc. | 10 | $278 |
| UCB, Inc. | 9 | $230 |
| TG Therapeutics, Inc. | 5 | $220 |
| ACADIA Pharmaceuticals Inc | 24 | $172 |
| Vanda Pharmaceuticals Inc. | 3 | $155 |
| JAZZ PHARMACEUTICALS INC. | 1 | $100 |
| Neurocrine BioSciences, Inc. | 5 | $100 |
| HARMONY BIOSCIENCES LLC | 1 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
Products named: QULIPTA, BRIUMVI, NUPLAZID, PONVORY, Symbravo, Fintepla, Sunosi, UBRELVY.
Industry payments across LA — which companies pay providers there.
